Perspective Therapeutics Stock Quote CATX - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

1.61

Bid

Ask

Volume

4,590,576

1.5311 Day's Range 1.62

0.205 52 Week Range 1.77

Market Cap

448.914M

Previous Close

1.60

Open

1.58

Last Trade

95602

1.58

Last Trade Time

Financial Volume

$ 7,228,394

VWAP

1.5746

Average Volume (3m)

4,086,622

Shares Outstanding

280,571,026

Dividend Yield

PE Ratio

-9.65

Earnings Per Share (EPS)

-0.17

Revenue

1.43M

Net Profit

-46.51M

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers incl... Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers including prostate cancer, head and neck, lung and brain. The Company has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also engaged in the development of imaging diagnostics (Pb-203 (Lead-203)). The Company¿s melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions. Show more

Sector

Eating Places

Industry

Surgical,med Instr,apparatus

Website

perspectivetherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1983

Perspective Therapeutics Inc is listed in the Eating Places sector of the American Stock Exchange with ticker CATX. The last closing price for Perspective Therapeutics was $1.60. Over the last year, Perspective Therapeutics shares have traded in a share price range of $ 0.205 to $ 1.77.

Perspective Therapeutics currently has 280,571,026 shares outstanding. The market capitalization of Perspective Therapeutics is $448.91 million. Perspective Therapeutics has a price to earnings ratio (PE ratio) of -9.65.

Perspective Therapeutics to Participate at Upcoming April Investor Conferences

SEATTLE, April 08, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results

SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers...

Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma

SEATTLE , March 18, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers...

Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024

SEATTLE, March 11, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or "the Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.17	11.8055555556	1.44	1.77	1.3597	5157803	1.62033579	CS
4	0.36	28.8	1.25	1.77	1.15	6495750	1.47978423	CS
12	0.787	95.6257594168	0.823	1.77	0.7178	4086622	1.27260402	CS
26	1.3489	516.621983914	0.2611	1.77	0.2201	2551690	1.08225022	CS
52	1.09	209.615384615	0.52	1.77	0.205	1602406	0.93810463	CS
156	1.2337	327.850119585	0.3763	1.77	0.205	1467488	0.9113423	CS
260	1.2337	327.850119585	0.3763	1.77	0.205	1467488	0.9113423	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M